139 related articles for article (PubMed ID: 28809501)
1. Microencapsulated Solid Lipid Nanoparticles as a Hybrid Platform for Pulmonary Antibiotic Delivery.
Gaspar DP; Gaspar MM; Eleutério CV; Grenha A; Blanco M; Gonçalves LMD; Taboada P; Almeida AJ; Remuñán-López C
Mol Pharm; 2017 Sep; 14(9):2977-2990. PubMed ID: 28809501
[TBL] [Abstract][Full Text] [Related]
2. Microencapsulated SLN: An innovative strategy for pulmonary protein delivery.
Gaspar DP; Serra C; Lino PR; Gonçalves L; Taboada P; Remuñán-López C; Almeida AJ
Int J Pharm; 2017 Jan; 516(1-2):231-246. PubMed ID: 27864069
[TBL] [Abstract][Full Text] [Related]
3. Rifabutin-loaded solid lipid nanoparticles for inhaled antitubercular therapy: Physicochemical and in vitro studies.
Gaspar DP; Faria V; Gonçalves LM; Taboada P; Remuñán-López C; Almeida AJ
Int J Pharm; 2016 Jan; 497(1-2):199-209. PubMed ID: 26656946
[TBL] [Abstract][Full Text] [Related]
4. Transfection of pulmonary cells by stable pDNA-polycationic hybrid nanostructured particles.
Gaspar DP; Vital J; Leiva MC; Gonçalves LM; Taboada P; Remuñán-López C; Vítor J; Almeida AJ
Nanomedicine (Lond); 2019 Feb; 14(4):407-429. PubMed ID: 30698066
[TBL] [Abstract][Full Text] [Related]
5. Microspheres containing lipid/chitosan nanoparticles complexes for pulmonary delivery of therapeutic proteins.
Grenha A; Remuñán-López C; Carvalho EL; Seijo B
Eur J Pharm Biopharm; 2008 May; 69(1):83-93. PubMed ID: 18166446
[TBL] [Abstract][Full Text] [Related]
6. Microencapsulated chitosan nanoparticles for lung protein delivery.
Grenha A; Seijo B; Remuñán-López C
Eur J Pharm Sci; 2005; 25(4-5):427-37. PubMed ID: 15893461
[TBL] [Abstract][Full Text] [Related]
7. Lipid Nanocarrier-Mediated Drug Delivery System to Enhance the Oral Bioavailability of Rifabutin.
Nirbhavane P; Vemuri N; Kumar N; Khuller GK
AAPS PharmSciTech; 2017 Apr; 18(3):829-837. PubMed ID: 27350276
[TBL] [Abstract][Full Text] [Related]
8. Inhalable locust bean gum microparticles co-associating isoniazid and rifabutin: Therapeutic assessment in a murine model of tuberculosis infection.
Grenha A; Alves AD; Guerreiro F; Pinho J; Simões S; Almeida AJ; Gaspar MM
Eur J Pharm Biopharm; 2020 Feb; 147():38-44. PubMed ID: 31790800
[TBL] [Abstract][Full Text] [Related]
9. Development and Evaluation of Chitosan Microparticles Based Dry Powder Inhalation Formulations of Rifampicin and Rifabutin.
Pai RV; Jain RR; Bannalikar AS; Menon MD
J Aerosol Med Pulm Drug Deliv; 2016 Apr; 29(2):179-95. PubMed ID: 26406162
[TBL] [Abstract][Full Text] [Related]
10. Rifabutin encapsulated in liposomes exhibits increased therapeutic activity in a model of disseminated tuberculosis.
Gaspar MM; Cruz A; Penha AF; Reymão J; Sousa AC; Eleutério CV; Domingues SA; Fraga AG; Filho AL; Cruz ME; Pedrosa J
Int J Antimicrob Agents; 2008 Jan; 31(1):37-45. PubMed ID: 18006283
[TBL] [Abstract][Full Text] [Related]
11. Design of a nanostructured lipid carrier intended to improve the treatment of tuberculosis.
Pinheiro M; Ribeiro R; Vieira A; Andrade F; Reis S
Drug Des Devel Ther; 2016; 10():2467-75. PubMed ID: 27536067
[TBL] [Abstract][Full Text] [Related]
12. Design, characterization, and aerosol dispersion performance modeling of advanced co-spray dried antibiotics with mannitol as respirable microparticles/nanoparticles for targeted pulmonary delivery as dry powder inhalers.
Li X; Vogt FG; Hayes D; Mansour HM
J Pharm Sci; 2014 Sep; 103(9):2937-2949. PubMed ID: 24740732
[TBL] [Abstract][Full Text] [Related]
13. Preparation of honokiol-loaded chitosan microparticles via spray-drying method intended for pulmonary delivery.
Li X; Guo Q; Zheng X; Kong X; Shi S; Chen L; Zhao X; Wei Y; Qian Z
Drug Deliv; 2009 Apr; 16(3):160-6. PubMed ID: 19514976
[TBL] [Abstract][Full Text] [Related]
14. Amsacrine analog-loaded solid lipid nanoparticle to resolve insolubility for injection delivery: characterization and pharmacokinetics.
Fang YP; Chuang CH; Wu PC; Huang YB; Tzeng CC; Chen YL; Liu YT; Tsai YH; Tsai MJ
Drug Des Devel Ther; 2016; 10():1019-28. PubMed ID: 27019595
[TBL] [Abstract][Full Text] [Related]
15. Solid lipid nanoparticles as promising tool for intraocular tobramycin delivery: Pharmacokinetic studies on rabbits.
Chetoni P; Burgalassi S; Monti D; Tampucci S; Tullio V; Cuffini AM; Muntoni E; Spagnolo R; Zara GP; Cavalli R
Eur J Pharm Biopharm; 2016 Dec; 109():214-223. PubMed ID: 27789355
[TBL] [Abstract][Full Text] [Related]
16. Preparation and in vitro, in vivo evaluations of norfloxacin-loaded solid lipid nanopartices for oral delivery.
Dong Z; Xie S; Zhu L; Wang Y; Wang X; Zhou W
Drug Deliv; 2011 Aug; 18(6):441-50. PubMed ID: 21554156
[TBL] [Abstract][Full Text] [Related]
17. In vitro characterization of 6-Coumarin loaded solid lipid nanoparticles and their uptake by immunocompetent fish cells.
Trapani A; Mandracchia D; Di Franco C; Cordero H; Morcillo P; Comparelli R; Cuesta A; Esteban MA
Colloids Surf B Biointerfaces; 2015 Mar; 127():79-88. PubMed ID: 25646741
[TBL] [Abstract][Full Text] [Related]
18. Design, characterization and in vitro evaluation of linalool-loaded solid lipid nanoparticles as potent tool in cancer therapy.
Rodenak-Kladniew B; Islan GA; de Bravo MG; Durán N; Castro GR
Colloids Surf B Biointerfaces; 2017 Jun; 154():123-132. PubMed ID: 28334689
[TBL] [Abstract][Full Text] [Related]
19. Antibiotic-free nanotherapeutics: ultra-small, mucus-penetrating solid lipid nanoparticles enhance the pulmonary delivery and anti-virulence efficacy of novel quorum sensing inhibitors.
Nafee N; Husari A; Maurer CK; Lu C; de Rossi C; Steinbach A; Hartmann RW; Lehr CM; Schneider M
J Control Release; 2014 Oct; 192():131-40. PubMed ID: 24997276
[TBL] [Abstract][Full Text] [Related]
20. Microencapsulated chitosan nanoparticles for pulmonary protein delivery: in vivo evaluation of insulin-loaded formulations.
Al-Qadi S; Grenha A; Carrión-Recio D; Seijo B; Remuñán-López C
J Control Release; 2012 Feb; 157(3):383-90. PubMed ID: 21864592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
